SEC Form 4 · accession 0001127602-18-032628
HAEMONETICS CORP · HAE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark W Kroll
Director
Period of report
Nov 7, 2018
Accepted (ET)
Nov 9, 2018 · 4:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000313143
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Aug 14, 2018 | G | 1,000 | $0.00 | D | 27,459 | D | |
| Common StockF2 | Aug 16, 2018 | G | 200 | $0.00 | D | 27,259 | D | |
| Common StockF2 | Nov 7, 2018 | M | 8,196 | $36.37 | A | 35,455 | D | |
| Common StockF2 | Nov 7, 2018 | S | 10,707 | $114.00 | D | 24,748 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified Stock Option (Right to Buy)F4 | $36.37 | Nov 7, 2018 | M | 8,196 | D | Jul 27, 2013 | Jul 27, 2019 | Common Stock | 8,196 | 0 | D |
Explanation of responses
- F1Shares transferred as a bona fide gift without any consideration.
- F2This number includes unvested restricted stock units previously reported.
- F3Transaction pursuant to an existing 10b5-1 trading plan.
- F4Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.